Proteq flu te rtu 1 dosage

PHARMACEUTICAL FORM Injectable suspension. SPECIES Horses. INDICATIONS Active immunization of horses 4 months of age or older against equine influenza by reducing the clinical signs and viral excretion after the infection and against tetanus to prevent mortality. - Start of immunity: 14 days after the primary vaccination. - Duration of immunity induced by vaccination schedule: 5 months after the primary vaccination. After the primary vaccination and the booster injection 5 months later, 1 year for equine influenza and 2 years for tetanus. DOSE / APPLICATION / ADMINISTRATION Route of administration: Intramuscular. Dosage: Administer one dose (1ml) by intramuscular injection, preferably in the neck, according to the following vaccination schedule: Primary vaccination with ProteqFlu-Te: first injection from 5 – 6 months, second injection 4 – 6 weeks later. Booster injection: 5 months after the primary vaccination with ProteqFlu-Te. Followed by or against tetanus: injection of 1 dose with a maximum interval of 2 years with ProteqFlu-Te. / Or against equine influenza: injection of 1 dose every year, alternatively with ProteqFlu. / Or ProteqFlu-Te, respecting an interval of 2 years for the tetanus component. It can be used during pregnancy and lactation. COMPOSITION QUALITATIVE AND QUANTITATIVE COMPOSITION Each dose of 1ml contains: Active substances: Recombinant canaripox virus Influenza A/eq/Ohio/03 [H3N8] (vCP2242): ≥ 5,3 log10 DIIF50* Recombinant canaripox virus Influenza A/eq/Richmond/1/07 [H3N8] (vCP3011): ≥ 5,3 log10 DIIF50* *vCP content checked by DIIF50 global (infectious dose 50 % by immunofluorescence) and qPCR ratio between vCP. Adjuvant: Carbomer: 4mg PRESENTATION 10 vials of 1ml